Success Story: Without RFE, We Helped a Fellow Physician from India Achieve NIW Approval

Posted by wegreened on January 30, 2026 in Medicine (Pharmaceutics, Pharmacology, Oncology, Pharmacognosy, Biomedical Engineering, Biomedicine), NIW

Client’s Testimonial:

“I am extremely grateful to Chen Immigration Attorneys for their exceptional guidance and support throughout my EB-2 NIW petition process. Their meticulous attention to detail and extensive expertise ensured that every aspect of my case was handled flawlessly. Not only were they highly knowledgeable, but they were also incredibly responsive, promptly addressing all my questions with clarity and professionalism. Thanks to their dedication and strategic approach, my petition was approved, and I couldn’t be happier with the outcome. I highly recommend WeGreened.com to anyone seeking reliable and expert immigration legal services.”

On May 23^rd, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Fellow Physician in the Field of Hematology and Medical Oncology (Approval Notice).

General Field: Hematology and Medical Oncology

Position at the Time of Case Filing: Fellow Physician

Country of Origin: India

State of Residence at the Time of Filing: New York

Approval Notice Date: May 23^rd, 2025

Processing Time: 11 months, 11 days

Case Summary:

We are pleased to report the successful approval of a National Interest Waiver (NIW) petition for an MD holder specializing in hematology and oncology research. The petition was approved after 11 months and 11 days, recognizing her significant contributions to advancing treatment strategies for cancer and blood disorders through clinical trials and evidence-based medicine.

Improving Outcomes in Hematology and Oncology

The client’s research focuses on the discovery of new therapeutics and the refinement of treatment protocols for hematologic malignancies and solid organ cancers. Her proposed endeavor emphasizes the conduct of high-quality clinical trials and literature reviews aimed at improving care outcomes for patients facing serious oncological and hematological conditions. By enrolling patients in trials and synthesizing data on modern treatment approaches, her work addresses urgent national healthcare needs.

Strong Academic Record and Medical Experience

Currently employed as a fellow physician in a leading medical center, the client has an extensive background in internal medicine, cancer research, and patient-centered clinical care. Her academic record includes 14 peer-reviewed journal articles, including 3 as first author, and 5 abstracts. These publications have been cited 171 times, with multiple papers ranking among the top 10% and 20% most cited in their field. Her COVID-19-related publications have been especially influential, with one article ranking in the top 0.1% of citations for its year.

Recognized Influence and Practical Impact

Beyond publication metrics, the petition demonstrated the client’s broader impact through real-world citation usage in surgical safety, drug safety, and thrombosis research. Her findings have directly informed other medical professionals’ work and contributed to clinical decision-making on a national and international level.

This case’s approval reflects both the petitioner’s proven track record and her future potential to enhance U.S. healthcare through innovative, evidence-based cancer and hematology research.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2020.01 - 2024.12)

Category	Approval or Refund^®		Approval or Refiling^TM
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	28,946	99.52%	3,030	98.31%
EB1A	4,322	91.76%	2,870	88.91%
EB1B	793	98.51%	236	90.77%
Total	34,061	98.44%	6,136	93.39%